News Focus
News Focus
Post# of 257443
Next 10
Followers 21
Posts 1903
Boards Moderated 0
Alias Born 06/06/2006

Re: poorgradstudent post# 202524

Monday, 07/11/2016 1:59:51 PM

Monday, July 11, 2016 1:59:51 PM

Post# of 257443
Poorgradstudent

I can't argue with you...because I dont have the knowledge ...even to try and post here the relevant info.

This is a study to a 3rd generation CAR...or sleeping beauty actually

https://www.researchgate.net/publication/304195746_Immunotherapy_of_acute_leukemia_by_chimeric_antigen_receptor-modified_lymphocytes_using_an_improved_Sleeping_Beauty_transposon_platform

I have read a lot and the IV ziop board has some good info as well as the publications out there...some studies also show under MD Anderson and other corraborators etc

I really think that Dr. Cooper is well regarded and has first hand knowledge of CAR, NK, TCR and if you would read some of his work and publications - i think that you would agree as well.

I have been trying to raise awareness on the biotech board as to this company, recent modifications to their agreement with XON which portend to a large deal for ZIOP, buyout etc

With regards to IL-12 - its been in the public domain for 20-30 years and yet nobody has been able to control the CRS etc....ZIOP did in their glioma studies and reversed grade 3-4 toxicities etc

http://www.ziopharm.com/content/02-pipeline/03-presentations-publications/3-asgct/1-regulated-expression-of-il-12-as-gene-therapy-concomitant-with-blockade-of-pd-1-for-treatment-of-glioma/asgct2016re.pdf

Md Anderson IP and other
http://www.investorvillage.com/smbd.asp?mb=16353&mn=11901&pt=msg&mid=14620320

Improving persistance of T cells in CAR thru IL15

http://www.investorvillage.com/smbd.asp?mb=16353&mn=46725&pt=msg&mid=15835364


Best wishes...

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today